Global Vessel Sealing Devices Market Grows Steadily at a CAGR of 4.67%

Introduction

A vessel sealing device is used during a minimally invasive surgical procedure to cut, coagulate, separate, and seal the blood vessels. The vessels are frequently sealed using a variety of energy types. An AC is directed at the appropriate tissue in the vascular sealing devices' active electrodes circuit. Several factors are considered when choosing suitable vessel sealing devices, including dependability and effectiveness. These devices successfully seal vessels up to 7 mm in diameter. The advantages of these devices include the fact that they seal the blood vessels quickly and are highly safe and effective.

Market Dynamics

Growing Number of Surgical Procedures Drives the Global Market

The rising number of surgical procedures, primarily resulting from accidents, sports-related injuries, and cardiac surgeries, is the main factor influencing the growth of the global vessel sealing devices market. It is projected that an increasing preference for minimally invasive procedures would fuel market demand for vessel sealing devices. Robotic surgical instruments have also transformed minimally invasive surgery, and surgeons' acceptance of these instruments is expanding widely.

Technological Advancements Creates Tremendous Opportunities

The main difficulty in minimally invasive surgery is bleeding. The need to improve hemostasis is growing, which has accelerated the advancement of electrosurgical technology. Due to the expanding advancement in minimally invasive therapy and upcoming developments in vessel sealing devices to enhance surgical safety, quality, and outcomes, the market is anticipated to have a broader scope. Globally, the prevalence of chronic diseases is also increasing, and people with chronic illnesses live longer, which contributes to an increase in surgical procedures. In the upcoming years, there will be an increase in surgical procedures, driving market expansion.

Regional Analysis

North America is the most significant shareholder in the global vessel sealing devices market and is expected to grow at a CAGR of 4.45% during the forecast period. Most of it is primarily caused by the growing number of new medical devices that the FDA has approved, the growing use of surgical interventions by the American public, and the rise in the proportion of minimally invasive surgical procedures performed nationwide. According to the American Heart Association Research Report 2018, heart disease accounts for one in seven deaths in the United States. Coronary heart disease (CHD) is the leading cause of CVD-related death in the United States (43.8%), followed by stroke (16.8%), heart failure (9.0%), high blood pressure (9.4%), artery diseases (3.1%), and other CVDs (17.9%). The high prevalence of CVDs will probably lead to increased demand for vessel-sealing devices because many patients require heart surgeries for severe heart conditions.

Europe is expected to grow at a CAGR of 4.26%, generating USD 2,207.22 million during the forecast period. Germany has a sizable base of foreign companies working on developing products due to the rising prevalence of various diseases, the rising number of surgical procedures, and the rising geriatric population in the country, which is expected to drive the vessel sealing devices market. Consequently, the country's expanding use of vessel sealing technology is also fueled by the rise in organ transplantation. Additionally, vessel sealing is a successful technique for achieving hemostasis by sealing both venous and arterial branches of the primary renal vessels of the donor and recipient during nephrectomy and hepatectomy procedures for organ transplantation. As a result, the factors above are boosting the German market, which is expected to expand steadily soon.

The healthcare sector in Japan has increased over the last few years. The country also has a significant number of hospitals and an advanced healthcare infrastructure in the Asia-Pacific region. Furthermore, it is predicted that the increase in surgical procedures will increase demand for several procedures, increasing demand for vessel sealing devices. Even though vessel-sealing devices (VSDs) are frequently used in Japan for various surgical procedures, including thoracoscopic surgery, few studies have compared their efficacy and safety to thoracoscopic lobectomy procedures in humans. EnSeal, LigaSure, and Harmonic are the three disposable vessel-sealing products most frequently used in Japan. The International Society of Aesthetic Plastic Surgery reported 231,457 face and head operations in Japan in 2019. Eleven thousand six hundred twenty-three procedures were performed in surgery for the body and extremities that year (2019).

Key Highlights

• The global vessel sealing devices market was valued at USD 5,627.99 million in 2021. It is expected to reach USD 8,486.98 million by 2030, growing at a CAGR of 4.67% during the forecast period (2022–2030).
• Based on the product, the global vessel sealing devices market is bifurcated into generators, instruments, and accessories. The generators segment is the highest contributor to the market and is expected to grow at a CAGR of 4.14% during the forecast period.
• Based on application, the global vessel sealing device market is bifurcated into general and laparoscopic surgery. The general surgery segment owns the highest market share and is expected to grow at a CAGR of 4.50% during the forecast period.
• Based on the end-user, the global vessel sealing device market is bifurcated into hospitals and specialty clinics, and ambulatory surgical centers. The hospitals and specialty clinics segment is the highest contributor to the market and is expected to grow at a CAGR of 4.86% during the forecast period.
• North America is the most significant shareholder in the global vessel sealing devices market and is expected to grow at a CAGR of 4.45% during the forecast period.

Competitive Players

Competitive Players

The global vessel sealing devices market’s major key players are Medtronic PLC, B Braun Melsungen AG, Erbe Medical India Pvt. Ltd, Olympus Corporation, Ethicon US LLC (Johnson & Johnson), Boston Scientific Corporation, BOWA-electronic GmbH & Co. KG, OmniGuide Holdings Inc., CONMED Corporation, and Bolder Surgical Holdings Inc.

Recent Developments

Market News

• In September 2022, according to Medtronic plc, a world leader in healthcare technology, the LINQ II Insertable Cardiac Monitor (ICM) system is the first and only ICM to be given 510(k) clearance by the U.S. Food and Drug Administration (FDA) for use in pediatric patients over the age of 2 who have heart rhythm abnormalities and need long-term, continuous monitoring.
• In September 2022, Olympus increased its global footprint by investing EUR 32 million in new medical equipment repair facilities in Coimbra, Portugal.

Segmentation

Market Segmentation

By Product

• Generators
• Instruments
• Accessories

By Applications

• General Surgery
• Laparoscopic Surgery

By End-User

• Hospitals and Specialty Clinics
• Ambulatory Surgical Centers

By Regions

• North America
• Europe
• Asia-Pacific
• The Middle East and Africa
• South America